SWK Corporation (SWKH)
Bid | 13.21 |
Market Cap | 163.15M |
Revenue (ttm) | 40.68M |
Net Income (ttm) | 14.6M |
EPS (ttm) | 1.08 |
PE Ratio (ttm) | 12.33 |
Forward PE | 9.67 |
Analyst | n/a |
Ask | 14.18 |
Volume | 58,065 |
Avg. Volume (20D) | 19,550 |
Open | 13.96 |
Previous Close | 14.09 |
Day's Range | 13.25 - 13.97 |
52-Week Range | 12.00 - 16.24 |
Beta | 0.22 |
About SWKH
SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It a...

3 weeks ago · accessnewswire.com
SWK Holdings Announces Closing of Royalty Sale and $4.00 Per Share Special DividendDALLAS, TX / ACCESS Newswire / April 10, 2025 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company, today announced the closing of the pr...

1 month ago · accessnewswire.com
SWK Holdings Corporation Announces Financial Results for Fourth Quarter 2024Conference Call Scheduled for Thursday, March 20, 2025, at 09:00 a.m. CST Corporate Highlights Fourth quarter 2024 GAAP net income was $5.9 million, compared with GAAP net income of $2.8 million for t...